Valneva SE ( VALN) - Stock Earnings
VALN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -58.7 million USD | 56.0 million USD |
| 2026Q1 | -36.8 million USD | 35.4 million USD |
| 2026Q2 | -36.2 million USD | 40.5 million USD |
| 2026Q4 Est. | — | — |
VALN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -112.1 million USD | 169.9 million USD |
| 2024 | -12.8 million USD | 176.6 million USD |
| 2025 | -135.2 million USD | 205.0 million USD |
| 2026 Est. | — | — |
VALN
Price: $5.61
52 week price:
Earnings Per Share: -2.02 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 8187
Market Capitalization: 555.7 million